Item 2.02 Results of Operations and Financial Condition.

(a)

On January 6, 2023, HTG Molecular Diagnostics, Inc. issued a press release announcing certain preliminary financial results as of and for the year ended December 31, 2022. A copy of this press release is attached hereto as Exhibit 99.1.

The information in this item 2.02 and the attached exhibit 99.1 are being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits

Exhibit   Description
  No.

99.1        Press release of HTG Molecular Diagnostics, Inc. dated January 6, 2023

104       Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses